Log In
Print
BCIQ
Print
Print this Print this
 

Cerenis HDL (CER-001)

  Manage Alerts
Collapse Summary General Information
Company Cerenis Therapeutics S.A.
DescriptionComplex of recombinant apolipoprotein A-1 (APOA1) and charged phospholipids
Molecular Target Apolipoprotein A-1 (APOA1)
Mechanism of ActionCholesterol removal
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today